You are currently viewing a new version of our website. To view the old version click .

Molecular Targets and Mechanisms of Action of Anti-cancer Agents

This special issue belongs to the section “Medicinal Chemistry“.

Special Issue Information

Dear Colleagues,

The title of this Special Issue is “Molecular Targets and Mechanisms of action of Anti-Cancer Agents”. Recently, the treatments and outcomes of some cancers have significantly improved; however, other types of cancer showed little change in survival rates. Both synthetic and traditional anti-cancer drugs can cause side effects and develop drug resistance. Nowadays, it is important to find new anti-cancer agents with new mechanisms of action and identify new cellular targets and therapeutic strategies, which are both potent and selective against cancer cells. We welcome submissions of research related to these topics. The scope of this research is mainly focused on (but not limited to) the following topics:

  • Identifying promising compounds with in vitro and/or in vivo anti-cancer activity, and studies on elucidating their mechanisms of action;
  • Combinatorial chemotherapy that might increase selectivity or synthetic lethality;
  • Targeting new cellular targets that may offer cancer selectivity (novel inhibitors).

Dr. Peramaiyan Rajendran
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • targeted therapy
  • conventional therapy
  • chemoprevention
  • molecular mechanism
  • molecular target
  • combinatorial therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Molecules - ISSN 1420-3049